Annabel Helga Sophie Alig (Annabel H S Alig)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Metastatic Colorectal Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Arndt Stahler, Beeke Hoppe, Il-Kang Na, Luisa Keilholz, Lothar Müller, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer von Weikersthal, Eray Goekkurt, Stefan Kasper, Andreas Jay Kind, Annika Kurreck, Annabel Helga Sophie Alig, Swantje Held, Anke C Reinacher-Schick, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stinzing, Tanja Trarbach, Dominik Paul Modest
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Annabel Helga Sophie Alig, Volker Heinemann, Michael Geissler, Ludwig Fischer von Weikersthal, Thomas Decker, Kathrin Heinrich, Swantje Held, Lena Weiss, Laura E Fischer, Nicolas Moosmann, Arndt Stahler, Ivan Jelas, Annika Kurreck, Jobst Christian von Einem, Anke C Reinacher-Schick, Andrea Tannapfel, Clemens Giessen-Jung, Sebastian Stinzing, Dominik P Modest
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy. Cancers 14 (3) (2022)
Arndt Stahler, Volker Heinemann, Julian Walter Holch, Jobst Christian von Einem, Christoph Benedikt Westphalen, Kathrin Heinrich, Laura Schlieker, Ivan Jelas, Annabel Helga Sophie Alig, Laura Elisabeth Fischer, Lena Weiss, Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Markus Moehler, Florian Kaiser, Thomas Kirchner, Andreas Jung, Sebastian Stinzing
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3). International journal of cancer 149 (11) (2021)